Ghazala Quraishi
Neurology · Atlanta, GANPI 1235204058
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,638 of the $12,007 with a category attached, or 88.6%. It is spread thinly across 42 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,720 and has fallen 59.5% since, to $1,102 in 2025.
Across 444 payments — averaging $27.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$2K
- Harmony Biosciences LLC$1K
- Corium, LLC$879
- Jazz Pharmaceuticals Inc.$878
- Neurelis, Inc.$855
- Neos Therapeutics, LP$799
- plus $5K from 36 others
Across 3 payments — averaging $5024.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$15K
What the payments were for
- Consulting fees$5505%
- Speaking & faculty fees$5004%
- Food & beverage$10,63889%
- Education$3183%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Adzenys XR-ODT$662
- Cotempla XR-ODT$662
- OXTELLAR XR$613
- QELBREE$575
- Azstarys$359
- Wakix$231
- VALTOCO$125
- APTIOM$122
- Dyanavel XR$122
- XYREM$121
- UBRELVY$114
- AIMOVIG$113
- Fycompa$112
- XYWAV$111
- Epidiolex$107
- AJOVY$103
How this compares
$12,007 in reported general payments places this provider in the 75th percentile of 506 neurology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $510 |
Paid to pharmacies, not to this prescriber.
Other neurology in Atlanta
- Joash LazarusAtlanta$1.1M
- Jeffrey EnglishAtlanta$749K
- Frank BerensonAtlanta$527K
- Julio FlaminiAtlanta$501K
- Douglas StuartAtlanta$493K
- Robert GilbertAtlanta$412K
- Lawrence SeidenAtlanta$272K
- Jacqueline RosenthalAtlanta$241K
- Ben ThrowerAtlanta$203K
- Jaime Hatcher MartinAtlanta$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.